Qiana L. Matthews

Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule.

Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways.

Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.

Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.

Gene therapy: human germline genetic modifications--assessing the scientific, socioethical, and religious issues.

Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX.

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.

Strategies to overcome host immunity to adenovirus vectors in vaccine development.

Derivation of a triple mosaic adenovirus for cancer gene therapy.

Evaluation of adenovirus capsid labeling versus transgene expression.

HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

Current progress in the development of a prophylactic vaccine for HIV-1.

Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

Transforming growth factor β suppresses glutamate-cysteine ligase gene expression and induces oxidative stress in a lung fibrosis model.

Gene transfer of active Akt1 by an infectivity-enhanced adenovirus impacts β-cell survival and proliferation differentially in vitro and in vivo.

Using multivalent adenoviral vectors for HIV vaccination.

Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model.

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.

Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.

Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 gene.

Neural stem cell-derived exosomes mediate viral entry.